Browsing Harvard Medical School by Keyword "CD40L"
Now showing items 1-1 of 1
-
CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells
(Springer-Verlag, 2012)CD40L has a well-established role in enhancing the immunostimulatory capacity of normal and malignant B cells, but a formulation suitable for clinical use has not been widely available. Like other TNF family members, in ...